YUE, E.,
TUGUZBAEVA, G.M.,
CHEN, X.,
LI, A.,
SUN, X.,
DONG, C.,
LIU, Y.,
YU, Y.,
ZAHRA, S.M.,
JIANG, Y.,
BAI, Y.,
QIN, Y.,
SHAN, Q.,
DU, Z. (2019) of anthocyanin on oral squamous
cell carcinoma and identify effective targets for
therapy. Methods: Cellviability
WANG, K.,
LIU, H.,
LIU, J.,
WANG, X.,
TENG, L.,
ZHANG, J.,
CHEN, X.,
WANG, N.,
ZHONG, Y.,
HOU, X.,
JIANG, H.,
ZHANG, X.,
ZHAO, S.,
LIU, Y.,
YAO, Y.,
WANG, J.,
QU, Y.,
PENG, F.,
BEYLERLI, O.,
LIAO, X. (2019) Metabolic abnormality is one of the hallmarks of cancer
cells, and limiting material supply is a
, the tissue- and stage-specific activation of which plays a role in the management of the
cell differentiation
into effect.
The relevance of the problem under study is determined by the fact that in light of the
adoptedImportance of Novel Intraperitoneal Therapy of NF-kappa B Inhibitor DHMEQImportance of Novel Intraperitoneal
Therapy of NF-kappa B Inhibitor DHMEQ
TAMs (tumor-associated macrophages) are innate immune
cells, which are present in prostate cancer